Triple-drug combo inhaler for asthmatics with poor symptom control

New research shows that asthmatics who have poor symptom control could be benefited by using a three-drug combination inhaler. The standard treatment for these patients is a two-drug combination of an inhaled corticosteroid (ICS) and a long acting beta 2 agonist (LABA). The third ingredient added to the mix is a long acting muscarinic antagonist, add the researchers. This combination successfully improved lung function and reduced exacerbations of asthma wrote the researchers.

From http://besthealthnews.com/2019/10/triple-drug-combo-inhaler-for-asthmatics-with-poor-symptom-control/?utm_source=rss&utm_medium=rss&utm_campaign=triple-drug-combo-inhaler-for-asthmatics-with-poor-symptom-control

from
https://healthnews010.wordpress.com/2019/10/02/triple-drug-combo-inhaler-for-asthmatics-with-poor-symptom-control/

From https://jamesjohnson10.blogspot.com/2019/10/triple-drug-combo-inhaler-for.html

from
https://jamesjohnson10.wordpress.com/2019/10/02/triple-drug-combo-inhaler-for-asthmatics-with-poor-symptom-control/